Alma Opus is a plasma and radiofrequency resurfacing platform, not a laser. It covers both ends of the resurfacing spectrum on one system: a thermal RF applicator for patients who want visible improvement with no downtime, and fractional plasma RF for patients who accept a few days of recovery in exchange for a stronger result. That range is the reason clinics buy it. One platform holds the cautious patient and the ambitious one, and the combination of the two in a single session is where a lot of the best outcomes come from.
How does Opus compare with a CO2 laser?
This is the question every clinic asks, and the honest answer is the useful one. In published comparisons of fractional plasma against fractional ablative laser, the clinical results were equivalent and the downtime with Opus was shorter. That does not make CO2 redundant. Deep acne scarring and heavy photodamage are still CO2 territory, and Alma sells both. It means that for the large middle of the resurfacing market, texture, fine lines, mild laxity and general rejuvenation, Opus reaches the same endpoint with patients back in circulation sooner.
Why clinics reach for it around the eyes
Because Opus delivers plasma and radiofrequency rather than laser light, the periorbital area is far simpler to treat. The laser eye-shield workflow that makes upper and lower eyelids awkward on a CO2 platform does not apply in the same way, so practitioners can work close to the lash line with a cleaner clinical routine. Eyelid and periorbital tightening is one of the most requested treatments in Australian clinics and one of the hardest to deliver well, which makes this a bigger commercial point than it sounds.
What it treats
Full-face rejuvenation and full resurfacing, sagging skin and fine lines, periorbital and eyelid laxity, and body indications including stretch marks. Face and body applicators run from the same platform, so a clinic is not buying a face device and then a separate body device a year later.
Who operates it
The typical buyer is a doctor, and doctor-led clinics are where Opus tends to land first. It is not a doctor-only device, though. The protocols are structured enough that, with training and experience, treatment can be delegated to other clinical staff over time, which is what lets a clinic scale the treatment rather than bottleneck it on one practitioner. Operator rules vary by state and by device class, and Alma Lasers Australia walks each clinic through what applies before installation.
Buying from the manufacturer
Alma Lasers Australia is Alma’s own Australian subsidiary, covering New Zealand from Sydney, so training, protocol support, service and parts come from the team that sold you the platform. We do not publish list prices, because the configuration depends on which applicators your clinic will use. Bring your treatment prices and weekly bookings to a demo and we will build the numbers with you. Equipment finance is available through Medfin.
